Cargando…
Carboxypeptidase A4 negatively correlates with p53 expression and regulates the stemness of breast cancer cells
Background: Triple-negative breast cancer (TNBC) is an aggressive cancer subtype lacking effective treatment options, and p53 is the most frequently mutated or deleted gene. Carboxypeptidase A4 (CPA4) is an extracellular metallocarboxypeptidase, which was closely associated with aggressiveness. Alth...
Autores principales: | Wang, Yipeng, Xie, Yibin, Niu, Yanan, Song, Peng, Liu, Ye, Burnett, Joseph, Yang, Zhihua, Sun, Duxin, Ran, Yuliang, Li, Yang, Sun, Lichao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7976593/ https://www.ncbi.nlm.nih.gov/pubmed/33746592 http://dx.doi.org/10.7150/ijms.54954 |
Ejemplares similares
-
Serum carboxypeptidaseA4 levels predict liver metastasis in colorectal carcinoma
por: Sun, Lichao, et al.
Publicado: (2016) -
Association between expression of Carboxypeptidase 4 and stem cell markers and their clinical significance in liver cancer development
por: Sun, Lichao, et al.
Publicado: (2017) -
CPA4 is a Novel Diagnostic and Prognostic Marker for Human Non-Small-Cell Lung Cancer
por: Sun, Lichao, et al.
Publicado: (2016) -
Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer
por: Sun, Lichao, et al.
Publicado: (2017) -
MEOX1 Promotes Tumor Progression and Predicts Poor Prognosis in Human Non-Small-Cell Lung Cancer
por: Sun, Lichao, et al.
Publicado: (2019)